Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Learn which retirement index funds are the cheapest and what factors influence cost, turnover, and suitability.
14,364 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Two researchers are launching a dedicated effort to bring sustainability back into the AI conversation, promising mea...
Alumis stock over 300% has turned heads after a big healthcare investor trimmed its stake. This article breaks down w...
A major biotech fund boosted its Erasca stake after a monumental rise. This article unpacks the logic, risks, and tak...
A new AI chip contender is entering the arena. This guide examines whether could cerebras next nvidia? is a realistic...
A deal of this size reshapes risk, rewards, and portfolio strategy. Here is the thing investors should know and pract...
California’s latest budget proposal includes a $100 million fund to help homeowners bridge insurance gaps and acceler...
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
The Coinbase-backed Base blockchain introduces an MCP gateway that lets users control on-chain actions with natural l...
XRP faces a pivotal moment as regulatory clarity grows and ETF options inch closer. Analysts lay out the conditions t...
Bitcoin remains the anchor as June approaches, with institutional buyers scooping up BTC during pullbacks. This piece...
As the 10-year treasury yield approaches 5%, SCHG faces higher discount rates that could compress growth valuations. ...